scaleup week. 19 - 22 September 2022  
← Back to portfolio Porfolio / MIP Discovery

MIP Discovery

Bedfordshire-based nanotechnology business.

Company overview

MIP Discovery develops and manufactures nanoMIPs, linear MIPs, bulk MIP and Rationally Designed Polymers using its proprietary processes.

Molecularly Imprinted Polymers (MIPs) are ‘synthetic’ affinity reagents and the nanoMIP format provides a more robust alternative to antibodies, typically with similar or greater affinity coupled with additional unique characteristics.

The company was previously known as MIP Diagnostics.

Company information

Head office
  • Bedfordshire
CEO
  • Stephane Argivier
Chair
  • Jim Reid
BGF office
Investment date
  • Jul 2020
Total BGF investment
  • £2 million